Yingqing Liang
About
In The Last Decade
Yingqing Liang
10 papers receiving 300 citations
Peers
Comparison fields: 5 of 39
- Immunology 209
- Oncology 206
- Pulmonary and Respiratory Medicine 30
- Molecular Biology 27
- Surgery 25
Countries citing papers authored by Yingqing Liang
This map shows the geographic impact of Yingqing Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingqing Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingqing Liang more than expected).
Fields of papers citing papers by Yingqing Liang
This network shows the impact of papers produced by Yingqing Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingqing Liang. The network helps show where Yingqing Liang may publish in the future.
Co-authorship network of co-authors of Yingqing Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Yingqing Liang. A scholar is included among the top collaborators of Yingqing Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingqing Liang. Yingqing Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 9 | |
| 4 | 108 | |
| 5 | 13 | |
| 6 | Cetuximab combined with natural killer cells therapy: an alternative to chemoradiotherapy for patients with advanced non-small cell lung cancer (NSCLC). | 20 |
| 7 | 59 | |
| 8 | 31 | |
| 9 | 34 | |
| 10 | 29 | |
| 11 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.